NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









National Institute of Diabetes and Digestive and Kidney Diseases

National Institute of Diabetes and Digestive and Kidney Diseases

Bethesda, Marylandniddk.nih.gov

Overview

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is an institute within the U.S. National Institutes of Health (NIH). Its mission is to conduct and support medical research and research training, and to disseminate science-based information on a wide range of serious, chronic diseases. The institute provides funding for research through grants to universities and other medical research institutions, including through Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. It also supports government scientists conducting basic, translational, and clinical research.

Portfolio Companies

23

Investments

National Institute of Diabetes and Digestive and Kidney Diseases investments
CompanyDateStageLead
Syntis Bio, Inc.Jul 2025GrantCo-investor
HepaTx CorporationMay 2025GrantLead
Ancilia BiosciencesOct 2024GrantCo-investor
Xylyx BioSep 2024GrantLead
GelSana TherapeuticsSep 2024GrantCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBethesda, Maryland
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.